Valo SPAC Presentation Deck
Valo is a technology company built to transform the pharmaceutical
industry, led by a deeply experienced team
Therapeutic products
>100
drug approvals¹
Process and scale
Drug development
BIG
PHARMA
excellence
Valo
6. Cutting edge
BIOTECH
I science
durability
Scalability and
BIG TECH
IN
Science and innovation
>1,000
regulatory filings¹
Data and compute
>1,000
clinical trials¹
Valo Valo data aggregates historical experience across Valo staff
[2] As of April 15, 2021
David Berry, MD, PhD
Founder, CEO
Founder Indigo (#1, #3 CNBC Disruptor),
MCRB, EVLO, AXLA, TTOO, Omega Tx,
etc.; GP Flagship Pioneering
Brett Blackman, PhD
Chief Innovation Officer
Founder, CSO of HemoShear,
Repertoire, and Kintai; Associate
Professor of Biomedical Eng, UVA
Moni Miyashita, MBA
Chief Strategy Officer
Partner, Innosight
VP, Corporate Development, IBM
>28,000
Al models deployed¹
Brandon Allgood,
PhD
Chief Al Officer
Co-founder & CTO, Numerate
Nish Lathia, MBA
Chief Product Officer
General Manager for multiple WW
businesses, Amazon
Dan Troy, JD
Chief Legal Officer &
General Counsel
General Counsel, GSK
Chief Counsel, FDA
>115 FTES at the convergence of life sciences and technology²
Graeme Bell, MBA,
FCMA
Chief Financial Officer
CFO, Tmunity / Intellia / Anacor
CFO, Merck U.S.
Hilary Malone, PhD
Chief Operating Officer,
Pharma
Chief Regulatory Officer, Sanofi
Cissy Young, PhD
Chief People Officer
Managing Director, Russell
Reynolds Associates;
Director, Strategy & BD, Cerulean
Pharma
2Q21
7View entire presentation